İnflamatuvar Bağırsak Hastalığında Komplikasyonların Bir Göstergesi Olarak Fekal Kalprotektin: Erkut ve Arkadaşlarının Makalesi Üzerine Bir Yorum

Year 2025, Volume: 15 Issue: 3, 144 - 145, 31.05.2025

Batuhan Başpınar , İbrahim Ethem Güven

https://doi.org/10.16899/jcm.1582362

https://izlik.org/JA32NG69PN

Abstract

Abstract is not required for letter to editor.
Abstract is not required for letter to editor.

Keywords

Fekal kalprotektin , inflamatuvar bağırsak hastalığı , komplikasyonlar , akut faz reaktanları

Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al.

https://izlik.org/JA32NG69PN

Abstract

Abstract is not required for letter to editor.
Abstract is not required for letter to editor.

Keywords

Fecal calprotectin , inflammatory bowel disease , complications , acute phase reactants

References

• 1. Erkut M, Ozkaya E, Fidan S, Cosar AM. Fecal Calprotectin at the Time of Diagnosis May Indicate the Presence of Complications in Inflammatory Bowel Disease. J Contemp Med. 2024;14(1):1-8. 2. Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99:1051-62. 3. Goldstone RN, Steinhagen RM. Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am.2019;99:1141-50. 4. Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56:307-20. 5. Sipponen T, Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:74-80.